MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 214 filers reported holding IMMUNOMEDICS INC in Q3 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.

Quarter-by-quarter ownership
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2020$16,974,000
+173.6%
478,944
+4.1%
0.01%
+133.3%
Q1 2020$6,205,000
-37.7%
460,290
-2.3%
0.00%
-25.0%
Q4 2019$9,965,000
+59.6%
470,949
+0.0%
0.00%
+33.3%
Q3 2019$6,243,000
-4.8%
470,806
-0.4%
0.00%0.0%
Q2 2019$6,555,000
-27.4%
472,615
+0.6%
0.00%
-25.0%
Q1 2019$9,026,000
+11.7%
469,880
-17.0%
0.00%0.0%
Q4 2018$8,082,000
-30.1%
566,384
+2.1%
0.00%
-20.0%
Q3 2018$11,557,000
-12.0%
554,830
-0.0%
0.01%
-16.7%
Q2 2018$13,135,000
+64.3%
554,914
+1.4%
0.01%
+100.0%
Q1 2018$7,995,000547,2200.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,711,067$2,943,0001.70%
J.P. Turner & Co Capital Mnagement, LLC 248,625$428,0000.44%
Orbimed Advisors 3,323,000$5,716,0000.06%
BALYASNY ASSET MANAGEMENT L.P. 2,004,078$3,447,0000.02%
WOLVERINE ASSET MANAGEMENT LLC 5,870$1,018,0000.02%
SIGNET FINANCIAL MANAGEMENT, LLC 44,675$77,0000.02%
SVB WEALTH LLC 195,000$335,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 288,900$497,0000.01%
J.P. Turner & Co Capital Mnagement, LLC 153,900$8,0000.01%
BALYASNY ASSET MANAGEMENT L.P. 640,400$1,101,0000.01%
View complete list of IMMUNOMEDICS INC shareholders